A new method has been developed to make drugs ‘smarter’ using nanotechnology so they will be more effective at reaching their target.
Scientists from the University of Lincoln, UK, have devised a new technique to ‘decorate’ gold nanoparticles with a protein of choice so they can be used to tailor drug to more accurately target an area on the body, such as a cancer tumour.
Gold nanoparticles are spheres made of gold atoms having a diameter of only few billionths of a metre which can be coated with a biological protein and combined with drugs to enable the treatment to travel through the body and reach the affected area.
The nanoparticles can ‘adsorb’ (hold on its surface) drugs which would otherwise become insoluble or quickly degrade in the blood stream, and due to their small size they can overcome biological barriers such as membranes, skin and the small intestine which would usually prevent the drug from reaching its target.
The technology is already used in real world applications such as pregnancy tests – where gold nanoparticles decorated with an antibody against the hormone present in the urine of pregnant women is added to the ‘positive’ strip so it reacts with the nanoparticles to turn the stick red – but is not yet widely used in drug development.
Until now the process of coating the nanoparticles meant that the proteins used had to be ‘mixed’ together with particles which do not have the ability to control the way they bind, possibly making the drug less effective. The new method enables pharmacologists to place the proteins onto the gold nanoparticles layer by layer in a specific order. This maintains the integrity of the protein so that the drug is more effective, opening up possibilities for the development of nanomedicine.
The findings have been published in the journal Nature Communications.
Dr Enrico Ferrari, a nanobiotechnologist from the University of Lincoln’s School of Life Sciences, led the study. He said: “Gold nanoparticles are a vital tool in new drug development and drug delivery systems. We have unlocked the key to binding proteins and molecules so that those drugs will be more effective.
“This method might help to design nanomedicines that do not need extensive chemical modification of a protein drug or a nano-carrier and therefore can be developed more easily and faster.”
Researchers took fragments of proteins from bacteria and flatworms, which when fused together were effective at binding to the gold nanoparticle surface and able to form stable bonds to any other protein.
By mixing this fusion protein with gold nanoparticles, it permanently binds to the gold surface while also being able to stably bind a target protein on which a specific ‘tag’ was included.
This is a new universal method to bind proteins to nanoparticles which will work for most proteins, making the process a more attractive prospect for pharmaceutical companies, the researchers said. The method could also potentially be applied to biosensors and diagnostic kits that use gold, such as those used in clinical settings to identify ongoing infections in patients’ blood.
Learn more: Nanomedicine: Drugs can be made ‘smarter’
The Latest on: Smart drugs
via Google News
The Latest on: Smart drugs
- SMART researchers develop customised targeting of bacteria using lysinson December 1, 2020 at 8:14 am
Researchers from SMART have developed a method to produce engineered lysins that can be used to selectively kill bacteria of interest while leaving others unharmed. The discovery presents a promising ...
- Scott Watson, convicted of murdering Olivia Hope and Ben Smart, bids for parole at hearingon December 1, 2020 at 8:03 am
The man convicted of murdering Olivia Hope and Ben Smart in the Marlborough Sounds will make a bid for freedom this week.
- Clean Republic Expands Its Smart Clean Movement With Consumer Launch Of Its EPA And ECHA-Approved Disinfectant + Sanitizeron December 1, 2020 at 7:37 am
PRNewswire/ -- Clean Republic, makers of OMRI-certified, nature-derived cleaning products, today announced the U.S. consumer launch of their EPA ...
- Ipsen expects to generate over $3 billion by 2024 for drug pipeline expansionon December 1, 2020 at 4:16 am
French healthcare company Ipsen said on Tuesday that it expects to generate about 3 billion euros ($3.59 billion) by 2024, excluding asset sales, to power the expansion of its drug pipeline.
- Smart Inhalers Market | Know the Exclusive Trends and Opportunities in the Marketon November 30, 2020 at 10:58 pm
Smart inhalers are increasingly becoming the preferred course of managing and treating respiratory diseases. An increasing number of companies are implementing digital technologies in their products ...
- Got $50? Four smart stocks to buy into right nowon November 28, 2020 at 4:12 am
If you have $50 you can spare for investing, I'd suggest buying into the following four smart stocks right now. Will gifts arrive in time for Christmas?: Target, Macy's, other stores offering same-day ...
- Editorial: Drug regulation got outsourcedon November 27, 2020 at 5:18 am
And second, it blindly adopts other countries' priorities when it comes to drug pricing, rather than having the U.S. government try to determine a treatment's value and then either negotiate for that ...
- Can smart ports curb drug trafficking?on November 27, 2020 at 3:19 am
The reduction in air traffic and increased security on roads due to Covid-19 restrictions have redirected drug shipments to the sea and authorities are struggling to respond. Innovative technologies ...
- Lantern: Early Stage 'Smart Drug' Discovery Companyon November 25, 2020 at 2:46 pm
Lantern works at the intersection of Artificial Intelligence, Genomics, and Machine Learning. It discovers novel oncology assets using its platform.
via Bing News